Sera Prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. Seras tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health.
